Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetrahydrocannabivarin as a Treatment for Smokers
NCT07636356Phase 2Not yet recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Oct 2026
- Primary completion
- May 2028
01
Overview
A Phase 2 trial of tetrahydrocannabivarin in Tobacco Use Disorder (TUD), sponsored by University of California, Los Angeles. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
tetrahydrocannabivarin
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT07636356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07636356.